Association between Salivary Mitochondrial DNA Copy Number and Chronic Fatigue according to Combined Symptoms in Korean Adults
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: We examined the association between salivary mitochondrial DNA (mtDNA) copy number and chronic fatigue combined with depression and insomnia.Methods: This cross-sectional study included 58 healthy adults with moderate to severe fatigue (Brief Fatigue In-ventory [BFI] ≥4) for longer than 6 months. Subjects were classified as those without combined symptoms, with ei-ther depression (Beck Depression Inventory [BDI] ≥13) or insomnia (Pittsburgh Sleep Quality Index [PSQI] ≥5), or with both depression and insomnia. Salivary mtDNA copy number was measured by real-time quantitative poly-merase chain reaction. The association was evaluated using a general linear model.Results: About 76% of participants had either depression or insomnia as additional symptoms. These subjects were predominately female, drank more alcohol, and exercised less than those without combined symptoms (P<0.05). The group with both depression and insomnia exhibited significantly higher BFI and lower mtDNA copy number than those without combined symptoms (P<0.05). After adjusting for confounding factors, significant negative as-sociations between mtDNA copy number and usual fatigue were found in the group without combined symptoms, whereas the negative associations in the group with combined symptoms were attenuated. BDI and PSQI were not associated with mtDNA copy number.Conclusion: Chronic fatigue is negatively associated with salivary mtDNA copy number. Salivary mtDNA copy number may be a biological marker of fatigue with or without combined symptoms, indicating that a separate ap-proach is necessary.
Abstract
Background: We examined the association between salivary mitochondrial DNA (mtDNA) copy number and chronic fatigue combined with depression and insomnia.Methods: This cross-sectional study included 58 healthy adults with moderate to severe fatigue (Brief Fatigue In-ventory [BFI] ≥4) for longer than 6 months. Subjects were classified as those without combined symptoms, with ei-ther depression (Beck Depression Inventory [BDI] ≥13) or insomnia (Pittsburgh Sleep Quality Index [PSQI] ≥5), or with both depression and insomnia. Salivary mtDNA copy number was measured by real-time quantitative poly-merase chain reaction. The association was evaluated using a general linear model.Results: About 76% of participants had either depression or insomnia as additional symptoms. These subjects were predominately female, drank more alcohol, and exercised less than those without combined symptoms (P<0.05). The group with both depression and insomnia exhibited significantly higher BFI and lower mtDNA copy number than those without combined symptoms (P<0.05). After adjusting for confounding factors, significant negative as-sociations between mtDNA copy number and usual fatigue were found in the group without combined symptoms, whereas the negative associations in the group with combined symptoms were attenuated. BDI and PSQI were not associated with mtDNA copy number.Conclusion: Chronic fatigue is negatively associated with salivary mtDNA copy number. Salivary mtDNA copy number may be a biological marker of fatigue with or without combined symptoms, indicating that a separate ap-proach is necessary.
참고문헌 (31)
- Yun YH, "Fatigue in the general Korean population : application and normative data of the Brief Fatigue Inventory", J Pain Symptom Manage, 36, pp.259~267 (2008)
- Robinson RL, "The importance of unresolved fatigue in depression : costs and comorbidities", Psychosomatics, 56, pp.274~285 (2015)
- Wong WS, "The co-morbidity of chronic pain, insomnia, and fatigue in the general adult population of Hong Kong: prevalence and associated factors", J Psychosom Res, 73, pp.28~34 (2012)
- Kallestad H, "The role of insomnia in the treatment of chronic fatigue", J Psychosom Res, 78, pp.427~432 (2015)
- Schwarz R, "Fatigue in the general population", Onkologie, 26, pp.140~144 (2003)
- Cohen BH, "Mitochondrial cytopathy in adults: what we know so far", Cleve Clin J Med, 68, pp.625~626 (2001)
- Pieczenik SR, "Mitochondrial dysfunction and molecular pathways of disease", Exp Mol Pathol, 83, pp.84~92 (2007)
- Clay Montier LL, "Number matters : control of mammalian mitochondrial DNA copy number", J Genet Genomics, 36, pp.125~131 (2009)
- Fattal O, "Review of the literature on major mental disorders in adult patients with mitochondrial diseases", Psychosomatics, 47, pp.1~7 (2006)
- Castro-Marrero J, "Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia?", Antioxid Redox Signal, 19, pp.1855~1860 (2013)
- He Y, "Leukocyte mitochondrial DNA copy number in blood is not associated with major depressive disorder in young adults", PLoS One, 9, pp.e96869~ (2014)
- Chang CC, "Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder", PLoS One, 10, pp.e0125855~ (2015)
- Tyrka AR, "Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults", Exp Gerontol, 66, pp.17~20 (2015)
- Jakupciak JP, "Performance of mitochondrial DNA mutations detecting early stage cancer", BMC Cancer, 8, pp.285~ (2008)
- Abraham JE, "Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping", BMC Med Genomics, 5, pp.19~ (2012)
- Yun YH, "Validation study of the korean version of the brief fatigue inventory", J Pain Symptom Manage, 29, pp.165~172 (2005)
- Lee JI, "Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea", Health Qual Life Outcomes, 8, pp.101~ (2010)
- Hahn HM, "A standardization study of the Beck Depression Inventory in Korea", J Korean Neuropsychiatr Assoc, 25, pp.487~502 (1986)
- Sohn SI, "The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index", Sleep Breath, 16, pp.803~812 (2012)
- Wang YC, "Mitochondrial DNA copy number correlates with oxidative stress and predicts mortality in nondiabetic hemodialysis patients", J Nephrol, 24, pp.351~358 (2011)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
- Filler K, "Association of mitochondrial dysfunction and fatigue : a review of the literature", BBA Clin, 1, pp.12~23 (2014)
- Croteau DL, "Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells", J Biol Chem, 272, pp.25409~25412 (1997)
- Lin SY, "The symptom cluster-based approach to individualize patient-centered treatment for major depression", J Am Board Fam Med, 27, pp.151~159 (2014)
- Hamon M, "Monoamine neurocircuitry in depression and strategies for new treatments", Prog Neuropsychopharmacol Biol Psychiatry, 45, pp.54~63 (2013)
- Smith AK, "Genetic evaluation of the serotonergic system in chronic fatigue syndrome", Psychoneuroendocrinology, 33, pp.188~197 (2008)
- WAY-100635, "Biol Psychiatry", 2005, 239~246
- Cleare AJ, "Contrasting neuroendocrine responses in depression and chronic fatigue syndrome", J Affect Disord, 34, pp.283~289 (1995)
- Rasbach KA, "5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis", J Pharmacol Exp Ther, 332, pp.632~639 (2010)
- Wu Z, "Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1", Cell, 98, pp.115~124 (1999)
- Fischer DB, "Chronic fatigue syndrome : the current status and future potentials of emerging biomarkers", Fatigue, 2, pp.93~109 (2014)